BRPI1015136A2 - composições de vacina para esquistossomose e métodos de uso - Google Patents

composições de vacina para esquistossomose e métodos de uso

Info

Publication number
BRPI1015136A2
BRPI1015136A2 BRPI1015136A BRPI1015136A BRPI1015136A2 BR PI1015136 A2 BRPI1015136 A2 BR PI1015136A2 BR PI1015136 A BRPI1015136 A BR PI1015136A BR PI1015136 A BRPI1015136 A BR PI1015136A BR PI1015136 A2 BRPI1015136 A2 BR PI1015136A2
Authority
BR
Brazil
Prior art keywords
methods
vaccine compositions
schistosomiasis vaccine
schistosomiasis
compositions
Prior art date
Application number
BRPI1015136A
Other languages
English (en)
Inventor
Afzal A Siddiqui
Gul Ahmad
Weidong Zhang
Original Assignee
Univ Texas Tech System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech System filed Critical Univ Texas Tech System
Publication of BRPI1015136A2 publication Critical patent/BRPI1015136A2/pt
Publication of BRPI1015136B1 publication Critical patent/BRPI1015136B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22052—Calpain-1 (3.4.22.52)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

abstract not avaible
BRPI1015136-2A 2009-06-23 2010-06-23 Vacina contra esquistossomose BRPI1015136B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21938209P 2009-06-23 2009-06-23
US61/219,382 2009-06-23
PCT/US2010/039707 WO2011005593A2 (en) 2009-06-23 2010-06-23 Schistosomiasis vaccine compositions and methods of use

Publications (2)

Publication Number Publication Date
BRPI1015136A2 true BRPI1015136A2 (pt) 2017-01-17
BRPI1015136B1 BRPI1015136B1 (pt) 2019-10-15

Family

ID=43429786

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015136-2A BRPI1015136B1 (pt) 2009-06-23 2010-06-23 Vacina contra esquistossomose

Country Status (4)

Country Link
US (1) US9248169B2 (pt)
CN (2) CN102596226A (pt)
BR (1) BRPI1015136B1 (pt)
WO (1) WO2011005593A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153290B (zh) * 2015-08-21 2019-03-15 复旦大学 日本血吸虫SjCTRL重组抗原蛋白及其制备方法和用途
CN114805524B (zh) * 2022-03-30 2023-07-04 中国医学科学院病原生物学研究所 日本血吸虫抗原蛋白rSjScP92及其应用
CN114751970B (zh) * 2022-03-30 2023-07-04 中国医学科学院病原生物学研究所 日本血吸虫抗原蛋白rSjScP15及其应用
US20250353819A1 (en) * 2022-06-01 2025-11-20 Board Of Regents The University Of Nebraska Aryl hydantoin compounds and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090325298A1 (en) * 2005-11-15 2009-12-31 Kernodle Douglas S Pro-Apoptotic Bacteria and Compositions for Delivery and Expression of Antigens
CN101177684B (zh) * 2007-10-29 2011-10-05 内蒙古大学 羊型布鲁氏杆菌m5菌株核糖体蛋白l7/l12的基因、其编码蛋白及应用

Also Published As

Publication number Publication date
WO2011005593A2 (en) 2011-01-13
US20110091507A1 (en) 2011-04-21
BRPI1015136B1 (pt) 2019-10-15
US9248169B2 (en) 2016-02-02
CN107375917A (zh) 2017-11-24
CN102596226A (zh) 2012-07-18
WO2011005593A3 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
PT2424372T (pt) Composições antimicrobianas e métodos de uso relacionados
PT2929031T (pt) Composições de irna de pcsk9 e métodos de seu uso
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
SMT201500260B (it) Composti di tioacetato, composizioni e metodi d’uso
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI1008280A2 (pt) Formulações prebióticas e métodos mde uso
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI1007175A2 (pt) Polipeptídeos hidroxifenilpriruvato dioxigenase mutantes e métodos de uso
BR112012031416A2 (pt) solução aceleradora e uso de uma solução aceleradora
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
BR112012013148A2 (pt) formulação farmacêutica e uso
BRPI0908951A2 (pt) compostos de minociclina e método de uso dos mesmos
ECSP11011557A (es) Mimético de smac
BRPI1010567A2 (pt) composições sublinguais de dexmedetomidina e métodos de uso e aparelho que os emprega
BR112013014119A2 (pt) novos moduladores e métodos de uso
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
BR112013010331A2 (pt) composições adesivas crepadas e métodos de uso dessas composições
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
SMT201600264B (it) POLIMORFI E SOLVATI DI 4-[-2-[[5-METlL-1-(2-NAFTALENlL)-1H-PIRAZOL-3-IL]OSSl]ETlL]MORFOLINA CLORIDRATO
BR112013010988A2 (pt) composição fluída e uso
ME03766B (me) Određeni amino-pirimidini, njihove kompozicije, i metode njihove upotrebe

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/06/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/06/2010, OBSERVADAS AS CONDICOES LEGAIS